Mink Historical Balance Sheet
| INKT Stock | USD 0.68 0.01 1.45% |
Trend analysis of Mink Therapeutics balance sheet accounts such as Other Current Liabilities of 8.5 M or Total Current Liabilities of 13.7 M provides information on Mink Therapeutics' total assets, liabilities, and equity, which is the actual value of Mink Therapeutics to its prevalent stockholders. By breaking down trends over time using Mink Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Mink Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mink Therapeutics is a good buy for the upcoming year.
Mink Therapeutics Inventory |
|
Mink |
About Mink Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Mink Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Mink Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Mink Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Mink currently owns. An asset can also be divided into two categories, current and non-current.
Mink Therapeutics Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Mink Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Mink Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Mink Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Mink Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.Most accounts from Mink Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Mink Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Mink Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.At this time, Mink Therapeutics' Other Current Liabilities is comparatively stable compared to the past year. Total Current Liabilities is likely to gain to about 13.7 M in 2024, whereas Net Tangible Assets are likely to drop (484.6 K) in 2024.
| 2023 | 2024 (projected) | Short and Long Term Debt Total | 50.4M | 38.8M | Total Assets | 4.6M | 4.3M |
Mink Therapeutics balance sheet Correlations
Click cells to compare fundamentals
Mink Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mink Stock Analysis
When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.